Clinical, epidemiological and histopathological characterization of patients with actinic keratosis

RESUMEN: En otros países se han descrito ciertos factores relacionados con el desarrollo de queratosis actínica (QA). Objetivo: describir las características clínicas, epidemiológicas e histopatológicas de pacientes institucionales de Medellín, con diagnóstico de QA. Metodología: estudio descriptivo de pacientes con QA. Se aplicó una encuesta estructurada tomando datos demográficos, clínicos y relacionados con el desarrollo de la QA. Resultados: se incluyeron 153 pacientes (58 hombres [37,9%] y 95 mujeres [62,1%]), con edad promedio de 70 años. Tenían 75 años o más 64 pacientes (41,8%). Ciento ocho pacientes (70,6%) refirieron haber tenido un grado alto de exposición solar en la niñez; 76 (49,7%) tenían el antecedente de fumar y 16 de estos (21,1%) aún fumaban; 46 (30,1%) informaron el antecedente de un familiar con cáncer de piel. Setenta y tres (47,7%) realizaban las actividades tanto bajo techo como al aire libre; 80 (52,3%) informaron que se aplicaban protector solar y 37 (24,4%) usaban gorra o sombrero por la época en que fueron encuestados. Predominó el fototipo II (101 pacientes; 66%) y había daño actínico moderado en 76 (49,7%). Cuando hubo un solo patrón histológico predominó el atrófico (12%) y cuando hubo dos, el atróficohiperqueratósico (18,7%). Conclusiones: las características fenotípicas y de exposición de los pacientes con QA estudiados en Medellín (Colombia) son similares a las reportadas en la literatura.ABSTRACT: Several factors related with the development of actinic keratosis (AK) have been reported in other countries. Objective: To describe the clinical, epidemiological and histopathological characteristics of patients with diagnosis of AK in Medellín, Colombia. Methodology: This was a descriptive study of patients with AK. A structured survey including demographic, clinical and epidemiological information was applied. Results: 153 patients were included (58 men [37.9%] and 95 women [62.1%]) with an average age of 70 years. Sixty four patients (41.8%) were aged 75 years or more. With regard to their personal history, 108 individuals (70.6%) had a high degree of solar exposure during childhood; 76 (49.7%) reported the habit of smoking and 16 out of these (21.1%) still smoked. In 46 (30.1%) there was a family history of skin cancer. Regarding individual habits, 73 (47.7%) carried out both indoor and outdoor activities, 80 (52.3%) reported the use of sunscreen and 37 (24.4%) used hat or cap at the time of the study. Fitzpatrick´s type II phototype predominated (101 patients; 66%) and 76 (49.7%) had moderate actinic damage. The predominant single histologic subtype corresponded to the atrophic type (12%) and the main mixed subtype was the atrophichyperkeratotic subtype (18.7%). Conclusions: Clinical, epidemiological and histopathological features found among two institutional populations with AK in Medellin (Colombia) were similar to those reported in the literature

Fundamentos de cómputo paralelo y distribuido para HPC : Construcción y evaluación de aplicaciones

El eje central de la línea presentada son los temas de procesamiento paralelo y distribuido para HPC (fundamentos y aplicaciones). Interesa la construcción, evaluación y optimización de soluciones con algoritmos concurrentes, paralelos y distribuidos sobre diferentes plataformas de software y arquitecturas con múltiples procesadores (multicore, clusters de multicore, cloud y aceleradores como GPU, FPGA y Xeon Phi), los lenguajes y paradigmas de programación paralela (puros e híbridos), los modelos de representación de aplicaciones paralelas, los algoritmos de (mapping y scheduling), el balance de carga, las métricas de evaluación de complejidad y rendimiento (speedup, eficiencia, escalabilidad, consumo energético), y la construcción de ambientes para la enseñanza de la programación concurrente y paralela. Se propone aplicar los conceptos en problemas numéricos y no numéricos de cómputo intensivo y/o sobre grandes volúmenes de datos (búsquedas, simulaciones, n-body, imágenes, big data, reconocimiento de patrones, bioinformática, etc), con el fin de obtener soluciones de alto rendimiento. En la dirección de tesis de postgrado existe colaboración con el grupo HPC4EAS (High Performance Computing for Efficient Applications and Simulation) del Dpto. de Arquitectura de Computadores y Sistemas Operativos de la Universidad. Autónoma de Barcelona, y con el Departamento de Arquitectura de Computadores y Automática de la Universidad Complutense de Madrid, entre otros.Eje: Procesamiento Distribuido y ParaleloRed de Universidades con Carreras en Informática (RedUNCI

Fundamentos de cómputo paralelo y distribuido para HPC : Construcción y evaluación de aplicaciones

El eje central de la línea presentada son los temas de procesamiento paralelo y distribuido para HPC (fundamentos y aplicaciones). Interesa la construcción, evaluación y optimización de soluciones con algoritmos concurrentes, paralelos y distribuidos sobre diferentes plataformas de software y arquitecturas con múltiples procesadores (multicore, clusters de multicore, cloud y aceleradores como GPU, FPGA y Xeon Phi), los lenguajes y paradigmas de programación paralela (puros e híbridos), los modelos de representación de aplicaciones paralelas, los algoritmos de (mapping y scheduling), el balance de carga, las métricas de evaluación de complejidad y rendimiento (speedup, eficiencia, escalabilidad, consumo energético), y la construcción de ambientes para la enseñanza de la programación concurrente y paralela. Se propone aplicar los conceptos en problemas numéricos y no numéricos de cómputo intensivo y/o sobre grandes volúmenes de datos (búsquedas, simulaciones, n-body, imágenes, big data, reconocimiento de patrones, bioinformática, etc), con el fin de obtener soluciones de alto rendimiento. En la dirección de tesis de postgrado existe colaboración con el grupo HPC4EAS (High Performance Computing for Efficient Applications and Simulation) del Dpto. de Arquitectura de Computadores y Sistemas Operativos de la Universidad. Autónoma de Barcelona, y con el Departamento de Arquitectura de Computadores y Automática de la Universidad Complutense de Madrid, entre otros.Eje: Procesamiento Distribuido y ParaleloRed de Universidades con Carreras en Informática (RedUNCI

Fundamentos de cómputo paralelo y distribuido para HPC : Construcción y evaluación de aplicaciones

El eje central de la línea presentada son los temas de procesamiento paralelo y distribuido para HPC (fundamentos y aplicaciones). Interesa la construcción, evaluación y optimización de soluciones con algoritmos concurrentes, paralelos y distribuidos sobre diferentes plataformas de software y arquitecturas con múltiples procesadores (multicore, clusters de multicore, cloud y aceleradores como GPU, FPGA y Xeon Phi), los lenguajes y paradigmas de programación paralela (puros e híbridos), los modelos de representación de aplicaciones paralelas, los algoritmos de (mapping y scheduling), el balance de carga, las métricas de evaluación de complejidad y rendimiento (speedup, eficiencia, escalabilidad, consumo energético), y la construcción de ambientes para la enseñanza de la programación concurrente y paralela. Se propone aplicar los conceptos en problemas numéricos y no numéricos de cómputo intensivo y/o sobre grandes volúmenes de datos (búsquedas, simulaciones, n-body, imágenes, big data, reconocimiento de patrones, bioinformática, etc), con el fin de obtener soluciones de alto rendimiento. En la dirección de tesis de postgrado existe colaboración con el grupo HPC4EAS (High Performance Computing for Efficient Applications and Simulation) del Dpto. de Arquitectura de Computadores y Sistemas Operativos de la Universidad. Autónoma de Barcelona, y con el Departamento de Arquitectura de Computadores y Automática de la Universidad Complutense de Madrid, entre otros.Eje: Procesamiento Distribuido y ParaleloRed de Universidades con Carreras en Informática (RedUNCI

Antimicrobial resistance among migrants in Europe: a systematic review and meta-analysis

BACKGROUND: Rates of antimicrobial resistance (AMR) are rising globally and there is concern that increased migration is contributing to the burden of antibiotic resistance in Europe. However, the effect of migration on the burden of AMR in Europe has not yet been comprehensively examined. Therefore, we did a systematic review and meta-analysis to identify and synthesise data for AMR carriage or infection in migrants to Europe to examine differences in patterns of AMR across migrant groups and in different settings. METHODS: For this systematic review and meta-analysis, we searched MEDLINE, Embase, PubMed, and Scopus with no language restrictions from Jan 1, 2000, to Jan 18, 2017, for primary data from observational studies reporting antibacterial resistance in common bacterial pathogens among migrants to 21 European Union-15 and European Economic Area countries. To be eligible for inclusion, studies had to report data on carriage or infection with laboratory-confirmed antibiotic-resistant organisms in migrant populations. We extracted data from eligible studies and assessed quality using piloted, standardised forms. We did not examine drug resistance in tuberculosis and excluded articles solely reporting on this parameter. We also excluded articles in which migrant status was determined by ethnicity, country of birth of participants' parents, or was not defined, and articles in which data were not disaggregated by migrant status. Outcomes were carriage of or infection with antibiotic-resistant organisms. We used random-effects models to calculate the pooled prevalence of each outcome. The study protocol is registered with PROSPERO, number CRD42016043681. FINDINGS: We identified 2274 articles, of which 23 observational studies reporting on antibiotic resistance in 2319 migrants were included. The pooled prevalence of any AMR carriage or AMR infection in migrants was 25·4% (95% CI 19·1-31·8; I2 =98%), including meticillin-resistant Staphylococcus aureus (7·8%, 4·8-10·7; I2 =92%) and antibiotic-resistant Gram-negative bacteria (27·2%, 17·6-36·8; I2 =94%). The pooled prevalence of any AMR carriage or infection was higher in refugees and asylum seekers (33·0%, 18·3-47·6; I2 =98%) than in other migrant groups (6·6%, 1·8-11·3; I2 =92%). The pooled prevalence of antibiotic-resistant organisms was slightly higher in high-migrant community settings (33·1%, 11·1-55·1; I2 =96%) than in migrants in hospitals (24·3%, 16·1-32·6; I2 =98%). We did not find evidence of high rates of transmission of AMR from migrant to host populations. INTERPRETATION: Migrants are exposed to conditions favouring the emergence of drug resistance during transit and in host countries in Europe. Increased antibiotic resistance among refugees and asylum seekers and in high-migrant community settings (such as refugee camps and detention facilities) highlights the need for improved living conditions, access to health care, and initiatives to facilitate detection of and appropriate high-quality treatment for antibiotic-resistant infections during transit and in host countries. Protocols for the prevention and control of infection and for antibiotic surveillance need to be integrated in all aspects of health care, which should be accessible for all migrant groups, and should target determinants of AMR before, during, and after migration. FUNDING: UK National Institute for Health Research Imperial Biomedical Research Centre, Imperial College Healthcare Charity, the Wellcome Trust, and UK National Institute for Health Research Health Protection Research Unit in Healthcare-associated Infections and Antimictobial Resistance at Imperial College London

Surgical site infection after gastrointestinal surgery in high-income, middle-income, and low-income countries: a prospective, international, multicentre cohort study

Background: Surgical site infection (SSI) is one of the most common infections associated with health care, but its importance as a global health priority is not fully understood. We quantified the burden of SSI after gastrointestinal surgery in countries in all parts of the world. Methods: This international, prospective, multicentre cohort study included consecutive patients undergoing elective or emergency gastrointestinal resection within 2-week time periods at any health-care facility in any country. Countries with participating centres were stratified into high-income, middle-income, and low-income groups according to the UN's Human Development Index (HDI). Data variables from the GlobalSurg 1 study and other studies that have been found to affect the likelihood of SSI were entered into risk adjustment models. The primary outcome measure was the 30-day SSI incidence (defined by US Centers for Disease Control and Prevention criteria for superficial and deep incisional SSI). Relationships with explanatory variables were examined using Bayesian multilevel logistic regression models. This trial is registered with ClinicalTrials.gov, number NCT02662231. Findings: Between Jan 4, 2016, and July 31, 2016, 13 265 records were submitted for analysis. 12 539 patients from 343 hospitals in 66 countries were included. 7339 (58·5%) patient were from high-HDI countries (193 hospitals in 30 countries), 3918 (31·2%) patients were from middle-HDI countries (82 hospitals in 18 countries), and 1282 (10·2%) patients were from low-HDI countries (68 hospitals in 18 countries). In total, 1538 (12·3%) patients had SSI within 30 days of surgery. The incidence of SSI varied between countries with high (691 [9·4%] of 7339 patients), middle (549 [14·0%] of 3918 patients), and low (298 [23·2%] of 1282) HDI (p < 0·001). The highest SSI incidence in each HDI group was after dirty surgery (102 [17·8%] of 574 patients in high-HDI countries; 74 [31·4%] of 236 patients in middle-HDI countries; 72 [39·8%] of 181 patients in low-HDI countries). Following risk factor adjustment, patients in low-HDI countries were at greatest risk of SSI (adjusted odds ratio 1·60, 95% credible interval 1·05–2·37; p=0·030). 132 (21·6%) of 610 patients with an SSI and a microbiology culture result had an infection that was resistant to the prophylactic antibiotic used. Resistant infections were detected in 49 (16·6%) of 295 patients in high-HDI countries, in 37 (19·8%) of 187 patients in middle-HDI countries, and in 46 (35·9%) of 128 patients in low-HDI countries (p < 0·001). Interpretation: Countries with a low HDI carry a disproportionately greater burden of SSI than countries with a middle or high HDI and might have higher rates of antibiotic resistance. In view of WHO recommendations on SSI prevention that highlight the absence of high-quality interventional research, urgent, pragmatic, randomised trials based in LMICs are needed to assess measures aiming to reduce this preventable complication

The Helicobacter pylori Genome Project : insights into H. pylori population structure from analysis of a worldwide collection of complete genomes

Helicobacter pylori, a dominant member of the gastric microbiota, shares co-evolutionary history with humans. This has led to the development of genetically distinct H. pylori subpopulations associated with the geographic origin of the host and with differential gastric disease risk. Here, we provide insights into H. pylori population structure as a part of the Helicobacter pylori Genome Project (HpGP), a multi-disciplinary initiative aimed at elucidating H. pylori pathogenesis and identifying new therapeutic targets. We collected 1011 well-characterized clinical strains from 50 countries and generated high-quality genome sequences. We analysed core genome diversity and population structure of the HpGP dataset and 255 worldwide reference genomes to outline the ancestral contribution to Eurasian, African, and American populations. We found evidence of substantial contribution of population hpNorthAsia and subpopulation hspUral in Northern European H. pylori. The genomes of H. pylori isolated from northern and southern Indigenous Americans differed in that bacteria isolated in northern Indigenous communities were more similar to North Asian H. pylori while the southern had higher relatedness to hpEastAsia. Notably, we also found a highly clonal yet geographically dispersed North American subpopulation, which is negative for the cag pathogenicity island, and present in 7% of sequenced US genomes. We expect the HpGP dataset and the corresponding strains to become a major asset for H. pylori genomics

Caracterización clínica, epidemiológica e histopatológica de pacientes con diagnóstico de queratosis actínica = Clinical, epidemiological and histopathological characterization of patients with actinic keratosis

Introducción: en otros países se han descrito ciertos factores relacionados con el desarrollo de queratosis actínica (QA).Objetivo: describir las características clínicas, epidemiológicas e histopatológicas de pacientes institucionales de Medellín, con diagnóstico de QA.Metodología: estudio descriptivo de pacientes con QA. Se aplicó una encuesta estructurada tomando datos demográficos, clínicos y relacionados con el desarrollo de la QA.Resultados: se incluyeron 153 pacientes (58 hombres [37,9%] y 95 mujeres [62,1%]), con edad promedio de 70 años. Tenían 75 años o más 64 pacientes (41,8%). Ciento ocho pacientes (70,6%) refirieron haber tenido un grado alto de exposición solar en la niñez; 76 (49,7%) tenían el antecedente de fumar y 16 de estos (21,1%) aún fumaban; 46 (30,1%) informaron el antecedente de un familiar con cáncer de piel. Setenta y tres (47,7%) realizaban las actividades tanto bajo techo como al aire libre; 80 (52,3%) informaron que se aplicaban protector solar y 37 (24,4%) usaban gorra o sombrero por la época en que fueron encuestados. Predominó el fototipo II (101 pacientes; 66%) y había daño actínico moderado en 76 (49,7%). Cuando hubo un solo patrón histológico predominó el atrófico (12%) y cuando hubo dos, el atróficohiperqueratósico (18,7%).Conclusiones: las características fenotípicas y de exposición de los pacientes con QA estudiados en Medellín (Colombia) son similares a las reportadas en la literatura

Surgical site infection after gastrointestinal surgery in children : an international, multicentre, prospective cohort study

Introduction Surgical site infection (SSI) is one of the most common healthcare-associated infections (HAIs). However, there is a lack of data available about SSI in children worldwide, especially from low-income and middle-income countries. This study aimed to estimate the incidence of SSI in children and associations between SSI and morbidity across human development settings. Methods A multicentre, international, prospective, validated cohort study of children aged under 16 years undergoing clean-contaminated, contaminated or dirty gastrointestinal surgery. Any hospital in the world providing paediatric surgery was eligible to contribute data between January and July 2016. The primary outcome was the incidence of SSI by 30 days. Relationships between explanatory variables and SSI were examined using multilevel logistic regression. Countries were stratified into high development, middle development and low development groups using the United Nations Human Development Index (HDI). Results Of 1159 children across 181 hospitals in 51 countries, 523 (45 center dot 1%) children were from high HDI, 397 (34 center dot 2%) from middle HDI and 239 (20 center dot 6%) from low HDI countries. The 30-day SSI rate was 6.3% (33/523) in high HDI, 12 center dot 8% (51/397) in middle HDI and 24 center dot 7% (59/239) in low HDI countries. SSI was associated with higher incidence of 30-day mortality, intervention, organ-space infection and other HAIs, with the highest rates seen in low HDI countries. Median length of stay in patients who had an SSI was longer (7.0 days), compared with 3.0 days in patients who did not have an SSI. Use of laparoscopy was associated with significantly lower SSI rates, even after accounting for HDI. Conclusion The odds of SSI in children is nearly four times greater in low HDI compared with high HDI countries. Policies to reduce SSI should be prioritised as part of the wider global agenda.Peer reviewe